Figure 3.
Illustrates the clinical timeline of the cohort, highlighting significant diagnostic delays and the prevalence of lymphoproliferation and infections from disease onset through follow-up. (
A and B
) Age at IEI onset, diagnosis, and follow-up. (C) Clinical features over time in the full cohort (N = 38).